Claim
correlational

Older adults with rheumatoid arthritis who have low levels of zinc, vitamin E, or magnesium are more likely to develop bone loss and die sooner, indicating that these nutrients may play a role in survival and bone health.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses

A systematic review could determine whether micronutrient supplementation reduces mortality or fracture risk in EORA.

A systematic review and meta-analysis of RCTs supplementing zinc, vitamin E, or magnesium in adults aged 65+ with EORA, measuring all-cause mortality, hip fracture incidence, and bone mineral density over ≥2 years.

2
Randomized Controlled Trials

An RCT could determine whether correcting micronutrient deficiencies improves survival or bone density in EORA.

A double-blind RCT of 300 adults aged 65+ with EORA and low serum zinc (<70 µg/dL), vitamin E (<12 µmol/L), or magnesium (<0.7 mmol/L), randomized to daily supplementation (zinc 15mg, vitamin E 400 IU, magnesium 300mg) vs. placebo for 3 years, with primary outcome: all-cause mortality and hip fracture incidence.

3
Cohort Studies
In Evidence

A cohort study could show whether low micronutrient intake predicts mortality in EORA over time.

A prospective cohort following 400 adults aged 65+ with EORA, measuring dietary intake of zinc, vitamin E, and magnesium via food frequency questionnaires annually for 8 years, adjusting for comorbidities, medication, and BMI.

4
Cross-Sectional Studies
In Evidence

A cross-sectional study could confirm the association between micronutrient levels and mortality risk in EORA.

A cross-sectional study comparing serum zinc, vitamin E, and magnesium levels in 200 deceased EORA patients vs. 200 living age-matched controls with EORA.

5
Case Reports & Case Series

A case series could document micronutrient levels in EORA patients with rapid disease progression or early mortality.

A case series of 10 EORA patients who died within 3 years of diagnosis, retrospectively analyzing serum zinc, vitamin E, and magnesium levels from prior clinical records.

Sign up to see full verdict